A relapsed APL patient had shown resistance to ATO and chemotherapy and was identified to harbor a point mutation (A216V) in the unrearranged <i>PML</i> allele rather than the <i>PML::RARα</i> fusion gene. This evidence concerns the gene PML and acute promyelocytic leukemia.